Our data claim that a rise in on-target off-tumor toxicity of daratumumab by ricolinostat is improbable in T cells and NK cells [32], even though regulatory T cells remain vunerable to daratumumab-mediated depletion. amounts suggesting the fact that upregulation of Compact disc38 expression on MM cells by HDAC6 inhibitors is a class effect. This proof-of-concept […]